The hidden hand

The uranium enricher behind your breath test

Russia's nuclear fuel company also separates the isotopes that diagnose stomach infections.

The number

Rosatom

Supply input

Supply input · Carbon-13 (C-13) Stable Isotope (Medical Diagnostics & Pharmaceutical)

Carbon-13 (13C) is a non-radioactive stable isotope of carbon constituting 1.1% of natural carbon. Enriched C-13 is produced by gas centrifuge separation of carbon monoxide (13CO vs. 12CO). Primary applications: (1) 13C-urea breath test — the gold standard non-invasive diagnostic for Helicobacter pylori infection (cause of stomach ulcers and gastric cancer); used in billions of tests globally; (2) 13C-labeled compounds for pharmaceutical metabolic studies and drug metabolism tracking; (3) Carbon-13 NMR spectroscopy for pharmaceutical structure determination. Russia (via Rosatom/TENEX) and Isotec/Sigma-Aldrich (US/Merck) are the primary global C-13 producers. The same centrifuge technology used for uranium enrichment also separates stable isotopes.

Surprise score

95 / 100

The same gas centrifuge cascades that enrich uranium for nuclear reactors produce Carbon-13 for medical diagnostics—the isotope that makes H. pylori breath tests work. Russia's state nuclear company controls this dual-use chokepoint, meaning the nonproliferation regime and global medical diagnostics depend on the same enrichment technology.

Source: Stable Isotope Technology -- International Atomic Energy Agency · International Atomic Energy Agency · Jan 1, 2024

Jump into the supply map

Where this story connects

The supplymap lets you trace the goods, inputs, and companies this story touches — see the full dependency chain, country shares, and historical incidents.

Companies

Tap for full company profile

More on Supply input · Carbon-13 (C-13) Stable Isotope (Medical Diagnostics & Pharmaceutical)

The uranium enricher behind your breath test

Where this story connects

Related stories